Results

Total Results: 1,987 records

Showing results for "harms".

101. Kidney-Disease-Medicine Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_executive.pdf
     January 01, 2012 - KQ4: Monitoring Harms KQ6: Treatment Harms Asymptomatic adults •With CKD risk factors •Without … Take into account potential screening harms. … increases harms. … Take into account potential monitoring harms. Key Question 4. … for worsening kidney function or damage increases harms.

102. Long-Term Drug Therapy and Drug Holidays for Osteoporotic Fracture Prevention | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/osteoporosis-fracture-prevention/research-protocol
     April 12, 2018 - Osteoporosis treatment harms vary by drug class. … harms of osteoporosis drug treatment holidays. … Predictors of of osteoporosis drug treatment holidays on incident fractures and harms. … Nonrare harms: Sample size must be ≥1000 and limited to prospective cohort studies. … Harms (Serious adverse events and specific harms as listed in Table 2 ) Outcome predictors (applicable

103. Searching for Relevant Studies Interactive Quiz (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/searching-quiz.ppt
     September 02, 2013 - You are interested in evaluating the benefits and harms associated with the use of thrombectomy devices … However, if the literature is extensive — and observational trials are allowed in the harms but not in … Harms searches are usually broader and include observational trials. … Searches usually include the harm (or subheadings for general harms) and the intervention. … However, if the literature is extensive — and observational trials are allowed in the harms but not in

104. App-F2-Surv-Report-2-Nonopioid-Pharmacol-Chronic-Pain (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f2-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
     September 20, 2022 - Harms of tricyclic antidepressants versus placebo Author, Year Quality Pain Population Drug Class Drug … Harms of pregabalin versus placebo Author, Year Quality Pain Population Drug Class Drug Assessment Time … Harms of pregabalin CR versus IR Author, Year Quality Pain Population Drug Class Drug Assessment Time … Harms of cannabis versus placebo Author, Year Quality Pain Population Drug Assessment Time (Wk) Time … Harms of lidocaine patch versus placebo Author, Year Quality Pain Population Drug Assessment Time (Wk

105. Hemorrhage-Postpartum Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hemorrhage-postpartum_executive.pdf
     April 01, 2015 - Harms of Interventions for PPH Harms varied considerably across the 50 studies reporting harms data … Among the 50 studies reporting harms, we considered 11 as good quality for harms reporting and the … for harms reporting. … poor quality for harms reporting. … • Prespecifying harms, differentiating harms of interventions from sequelae of PPH wherever possible

106. Disposition of Comments for Comparative Effectiveness Review No. 240: Treatments for Acute Pain: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-240-acute-pain-revised-comments.pdf
     December 29, 2020 - The report summarizes evidence on benefits as well as harms of NSAIDs. … The review summarized evidence on benefits as well as harms of NSAIDs. … Harms of opioids are well-described in the report. … Potential harms of opioids are described in the Background section. … This report focuses on benefits and harms of treatment for acute pain.

107. S16 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s16.pdf
     October 01, 2007 - Harms are variably and often poorly reported; TABLE 1. … Do benefits exceed harms in trials? … Will expected benefits exceed harms for me? … Can we similarly apply harms estimates from WHS? … Do benefits of CEA outweigh harms in trials?

108. Imaging Tests for the Diagnosis and Staging of Pancreatic Adenocarcinoma | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/cancer-pancreas/research
     September 23, 2014 - specificity), staging accuracy, screening accuracy, clinical management, quality of life, survival, and harms … For studies of a single imaging test, the key outcomes were accuracy and procedural harms. … For data on single-test accuracy, procedural harms, patient tolerance, and screening accuracy, we tabulated … Many studies have reported procedural harms, but harms are generally rare and are different for different

109. Opioid Treatments for Chronic Pain Research Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/opioid-treatments-chronic-pain-protocol.pdf
     December 19, 2018 - ; some harms (including overdose risk) were dose-dependent. … Harms and Adverse Events a. … harms, infections, cardiovascular events, cognitive harms, and psychological harms (e.g., depression … (including overdose, substance use disorder and misuse; other harms (including gastrointestinal harms … , cognitive harms, and psychological harms, including depression and suicidality).

110. Disposition of Comments: CER 234 Management of Primary Headaches in Pregnancy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-234-headaches-pregnancy-revised-comments.pdf
     November 12, 2020 - The EPC had inadvertently excluded a systematic review of indomethacin and its harms in pregnant women … overall, and paucity of studies in postpartum and breastfeeding women), contextual issues, and known harms … Reviewers suggested reorganizing the report such that the direct evidence (primary studies of benefits and harms … ) and indirect evidence (systematic reviews of harms) appear together in the same section for each intervention

111. Disposition of Comments: CER 234 Management of Primary Headaches in Pregnancy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-234-headaches-pregnancy-revised-comments.pdf
     November 12, 2020 - The EPC had inadvertently excluded a systematic review of indomethacin and its harms in pregnant women … overall, and paucity of studies in postpartum and breastfeeding women), contextual issues, and known harms … Reviewers suggested reorganizing the report such that the direct evidence (primary studies of benefits and harms … ) and indirect evidence (systematic reviews of harms) appear together in the same section for each intervention

112. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer18-heart-disease-ace-inhibitor-arb-executive.pdf
     October 01, 2009 - What is the evidence that benefits or harms differ by subpopulations, including: demographics [sex, age … The ACE inhibitor ramipril and the ARB telmisartan have similar efficacy, similar risks of harms, and … therefore a similar balance of benefits to harms. … Given the lack of significant benefits found in Key Question 3, the balance of benefits to harms for … Since there were no subgroup comparisons based on harms, the balance of benefits to harms in these subgroups

113. Lung Cancer Screening With Low-DoseComputed Tomography (LDCT) (pdf file)
     effectivehealthcare.ahrq.gov/decision-aids/lung-cancer-screening/static/lung-cancer-screening-clin-summary.pdf
     March 01, 2016 - eligibility of patients for lung cancer screening, ensuring patients understand the benefits and harms … Important harms of lung cancer screening with LDCT were also observed. … These harms included a high number of false- positive scans and the low predictive value ELIGIBILITY … Harms: What are the harms of screening for lung cancer with LDCT? … Radiation exposure (from screening and diagnostic imaging, including cumulative exposure) » Harms of

114. Lung Cancer Screening With Low-DoseComputed Tomography (LDCT) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/lung-cancer-screening-clin-summary.pdf
     March 01, 2016 - eligibility of patients for lung cancer screening, ensuring patients understand the benefits and harms … Important harms of lung cancer screening with LDCT were also observed. … These harms included a high number of false- positive scans and the low predictive value ELIGIBILITY … Harms: What are the harms of screening for lung cancer with LDCT? … Radiation exposure (from screening and diagnostic imaging, including cumulative exposure) » Harms of

115. Evidence Summary for CER 239: Acute Treatments for Episodic Migraine (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-239-acute-migraine-evidence-summary.pdf
     December 01, 2020 - Evidence about harms is also unclear. … They need information about the comparative effectiveness and harms of alternative therapies to the … This systematic review assesses the comparative effectiveness and harms for acute migraine treatments … Effectiveness and harms: • Tramadol in combination with acetaminophen may reduce pain at 2 hours and … trials evaluate the efficacy and harms of the treatments during one or a few attacks.

116. Disposition of Comments: CER 224, Treatment of Depression in Children and Adolescents: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-224-depression-children-comments.pdf
     April 10, 2020 - on harms. … on harms. … on harms. … profound harms of untreated depression. … on harms.”

117. Disposition of Comments: CER 224, Treatment of Depression in Children and Adolescents: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-224-depression-children-comments.pdf
     April 10, 2020 - on harms. … on harms. … on harms. … profound harms of untreated depression. … on harms.”

118. Evidence Summary_Comparative Effectiveness Review No. 248: Prehabilitation and Rehabilitation for Major Joint Replacement (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/Evidence%20Summary_0.pdf
     November 01, 2021 - o Prehabilitation prior to TKA may not increase the risk of harms (low SoE). … • Rehabilitation for Total Knee Arthroplasty (continued) o No studies addressed the risk of harms … o No studies compared prehabilitation to no rehabilitation on satisfaction with care or risk of harms … Prehabilitation prior to TKA may not increase the risk of harms (low SoE). … We found no evidence regarding harms from acute-phase rehabilitation.

119. Evidence Summary_Comparative Effectiveness Review No. 248: Prehabilitation and Rehabilitation for Major Joint Replacement (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/joint-replacement-evidence%20-summary.pdf
     November 01, 2021 - o Prehabilitation prior to TKA may not increase the risk of harms (low SoE). … • Rehabilitation for Total Knee Arthroplasty (continued) o No studies addressed the risk of harms … o No studies compared prehabilitation to no rehabilitation on satisfaction with care or risk of harms … Prehabilitation prior to TKA may not increase the risk of harms (low SoE). … We found no evidence regarding harms from acute-phase rehabilitation.

120. Key Questions: Treatment of Stage I-III Squamous Cell Carcinoma (SCC) of the Anal Canal (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/anal-cancer-key-questions.pdf
     January 01, 2018 - What is the effectiveness and what are the harms of radiation therapy in the palliative treatment of … Salvage rate  Sphincter preservation  Acute and late toxicity  Health-related quality of life  Harms … response Salvage rate Sphincter preservation Acute and late toxicity Health-related quality of life Harms … Acute and late toxicity Health-related quality of life 4 Health-related quality of life Harms … of treatment Harms of treatment Abbreviations: IMRT=intensity-modulated radiation therapy; 3-D CRT